ReviewClinical kidney journal2025

The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management.

Francesc Moncho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.